In this module of a Four-Part Expert Interview Series, Jeffrey Voner, MSHS, MPH, PA-C, DFAAPA, along with Aaron B. Waxman, MD, PhD, course chair, will outline recent treatment data for pulmonary arterial hypertension (PAH) as it relates to interprofessional patient care. Best practices for managing heart failure will be reviewed along with potential treatment directions after a confirmed diagnosis of PAH. Strategies for engaging the interprofessional team in providing comprehensive care and administering optimal patient education will be highlighted. Upon completion of this 30-minute module, learners will have a better understanding of strategies for creating effective treatment plans utilizing recent data regarding pulmonary arterial hypertension.
Pulmonologists, cardiologists, primary care physicians, internists, nurse practitioners, nurses, and other healthcare providers involved in the management of patients with PAH
1. Consider all available therapeutic options when making tailored treatment decisions for PAH patients
2. Collaborate with the multidisciplinary/interprofessional team to apply evidence-based strategies for improved outcomes in patients with PAH
Aaron B. Waxman, MD, PhD
Pulmonary and Critical Care Medicine
Director, Pulmonary Vascular Disease Program
Executive Director, Center for Pulmonary-Heart Diseases
Brigham and Women’s Hospital Heart and Vascular Center
Associate Professor of Medicine, Harvard Medical School
Jeffrey Voner, MSHS, MPH, PA-C, DFAAPA
Senior Physician Assistant
Pulmonary Vascular Program Clinical Coordinator
Pulmonary Hypertension Association Comprehensive Care Center Coordinator
Brigham and Women’s Hospital
Disclosures of Conflict of Interest
It is the policy of AcademicCME that all faculty, instructors, and planners disclose real or apparent conflicts of interest relating to the topics of this educational activity.
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CNE activity:
|Faculty||Relationship Identified With:|
|Aaron B. Waxman, MD, PhD||Consultant/Advisor: Acceleron Pharma, Inc.; Medtronic; United Therapeutics Corporation|
|Jeffrey Voner, MSHS, MPH, PA-C, DFAAPA||Nothing to disclose|
Planners, Managers, Reviewers
Timothy Hayes, MD, PhD; Emma Boring; Nicole Brestowski and Kim Cheramie, MSN, RN-BC hereby state that they or their spouse/life partner do not have any financial relationships to products or devices with any commercial interests related to the content of this activity of any amount during the past 12 months.
AcademicCME is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
AcademicCME is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission (ANCC) on Accreditation. AcademicCME’s ANCC provider number is P0491.
Credit Designation Statement
AcademicCME designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AcademicCME designates this enduring material for a maximum of 0.50 CNE contact hours (0.50 CNE pharmacotherapeutic contact hours).
This activity has been supported by an independent educational grant from Actelion Pharmaceuticals US, Inc.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. AcademicCME and Actelion Pharmaceuticals US, Inc. do not recommend the use of any agent outside of the labeled indications.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Method of Participation
1. Read the learning objectives, accreditation information and faculty disclosures at the beginning of this activity.
2. Complete the Pre-Activity Questions.
3. Read or Review the activity content.
4. Complete the Post-Activity Test Questions and Evaluation.
5. Healthcare providers who receive a grade of 70% or better on the Post-Activity Test Questions and who complete the Evaluation will receive a CME Certificate.
6. All other participants who receive a grade of 70% or better on the Post-Activity Test Questions and who complete the Evaluation will receive a Certificate of Participation.
7. Healthcare providers should claim only the credit commensurate with the extent of their participation in the activity.
CE Inquiries/Special Needs
For all CME/CNE inquiries or special needs, please contact [email protected].